Protecting Human Subjects in Research: Are Current Safeguards Adequate? AHRP Testimony submitted to Congressional Committee April 23, 2002 Vera Hassner Sharav, President, and John H. Noble, Jr., Ph.D., steering committee member, The Alliance for Human Research Protection (AHRP), before the Subcommittee on Public Health, Committee on Health, Education, Labor, &…
Florida Attorney General Subpoena’s Eli Lilly Re: Zyprexa documents Wed, 3 Aug 2005 Reuters reports that Eli Lilly received a subpoena in June from Florida’s Medicaid Fraud Control Unit of the Attorney General office which seeks documents pertaining to the marketing of Zyprexa. Lilly said “it was possible that other…
The Facts about Medicare “Wider Choices in Drug Benefits" Thu, June 16, 2005 The New York Times reports: “The expansion of Medicare to cover prescription drugs is President Bush’s most significant achievement in domestic policy. He plans to emphasize it at two events this week, on Thursday in Washington and…
WSJ: Debate Over Antidepressants: FDA role in suppressing damaging data Tue, 25 May 2004 How were drug manufacturers able to conceal vital evidence of harmful antidepressant drug effects? The answer is becoming clearer by the day: federal regulators and the psychiatrists who tested these drugs in clinical trials are invested…
August 7, 2002 University of California Seeks to Ease Curbs on Patient Protection in Research – LA Times FYI Thanks to a series of articles, in the San Francisco Chronicle and Los Angeles Times, the public has been made aware about the back-door efforts to pass a bill in California…
Glaxo chief: “Our drugs do not work on most patients” Mon, 8 Dec 2003 Dr. Allen Roses, worldwide vice-president of genetics at GlaxoSmithKline (GSK), Britain’s giant pharmaceutical company, acknowledged at a scientific meeting in London that fewer than half of the patients prescribed some of the most expensive drugs actually…
Bioethics Debate: Ethics of U Penn Surgical “Drug Implant” Experiment This debate between AHRP President, Vera Sharav and Bioethicist, Paul Root Volpe, Ph.D., University of Pennsylvania, was prompted by an October 7 infomail. The reasons for AHRP’s opposition to drug implants for psychiatric patients are explained here: https://ahrp.org/ahrpspeaks/drugimplant1103.php —–Original Message—–…
Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…
Are we all going mad, or are the experts crazy? / Are psychiatric drugs an assault on the human condition? Fri, 19 Aug 2005 Below, two companion pieces: An Op Ed in the Los Angeles Times, by Stuart Kirk, a professor of social welfare at UCLA, addresses psychiatry’s conundum: the…
Merck Baby Vaccines Not Pure – LAT/ FDA Advisory-Crestor / Zyprexa Lawsuit charges Lilly concealed Diabetes risk Fri, 11 Mar 2005 The FDA’s failure to carry out its watchdog responsibility to protect the public from unsafe drugs, has encouraged the pharmaceutical industry to conceal the risks and deceive the public….
NYU Students Drugged – NY Post Mon, 19 Apr 2004 Following three suicides by students at New York University (in Sept-October 2003), the University conducted an investigation of the NYU Student Counseling Services. The New York Post reports that an internal 116-page report (December 2003) reveals that whereas drugs were…
Freud Goes Up in Smoke – Toronto Star Sun, 16 Nov 2003 Neighbours: Freud And Hitler In Vienna, a just released film juxtaposes what Sophie Freud, granddaughter of the father of psychoanalysis calls two “false prophets of the 20th century.” Sigmund Freud, who was once regarded as a messiah and…
